As per our report, the size of the global prefilled syringes market is estimated to be USD 3.99 billion in 2020 and is expected to grow at a CAGR of 10.7%, to reach USD 6.63 billion by 2025. The prefilled syringes market is increasing majorly due to the increased incidence of chronic illness, increased demand for self-medication, and the growing elderly population around the world.
According to the Autoimmune Research Foundation, the spread of chronic inflammatory diseases is due to antibiotic abuse, vitamin supplementation, the presence of environmental factors that suppress immunity, new vectors sharing pathogens (including blood donations), and forced large Caused by the widespread use of large-scale vaccination.
MARKET DRIVERS
The development of technologically advance prefilled syringes and the growing demand for self-injected devices are the dominant trend in the prefilled syringes market. A large number of patient affected by chronic diseases are benefited by prefilled syringes as there is a need for continuous medication in chronic diseases, and this is driving the market.
The full availability and increasing use of single-cavity prefilled syringes are key factors driving the growth of the global prefilled syringes market. Due to lifestyle changes and the lack of preventive care opportunities, the healthcare industry has witnessed the prevalence of chronic diseases such as cardiovascular, cancer, respiratory and diabetes, especially in developing countries. It is merely to boost up the market demand for prefilled syringes.
The health care industries have witnessed the prevalence of chronic diseases such as diabetes, cardiovascular and cancer in the developing countries. It has boosted the market demand for prefilled syringes. The devices like pen injection are one of the significant selling product in prefilled syringes.
MARKET CHALLENGES
However, there are certain complexities associated, such as drug reaction with primary packaging may affect the prefilled syringes market growth to a certain extent. The response with plastic also affects the quality of the drugs, which is hampering the market growth.
REPORT COVERAGE
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2019 to 2025 |
|
Base Year |
2019 |
|
Forecast Period |
2020 to 2025 |
|
Segments Analysed |
By Material, Type, Design, Application, Distribution Channel and Region |
|
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Challenges, Opportunities, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
Regions Analysed |
North America, Europe, Asia-Pacific, Latin America, Middle East and Africa |
This research report on the Global Prefilled Syringes Market has been segmented and sub-segmented based on the material, type, design, application, distribution channel and region.
Prefilled Syringes Market - By Material:
Based on material, the glass segment contributed more than a 70% share of revenues in 2018. Glass has excellent barrier properties which make it a preferred material for the manufacture of prefilled syringes. The glass material prevents water and oxygen vapour from interacting with pharmaceuticals. Besides, the glass is compatible with various filling machines and medicines.
The plastic market segment is likely to reach a CAGR of more than 12% over the estimated forecast period. The plastic material is designed with a break and is flexible compared to glass. The polymers exhibit minimal drug absorption with reduced surface reactivity and excellent compatibility with pH change. Manufacturers have developed cyclic olefinic copolymers which offer high heat resistance and better visibility. The above advantages of plastic are contributing to the growth of the segment during the forecast period.
Prefilled Syringes Market - By Type:
Prefilled Syringes Market - By Design:
Based on the design, in 2019, Single chamber held the leading position in the market and expected to continue the same growth trends during the forecast period. Single-chamber prefilled syringes protect patients and clinicians from needle stick injuries that will augment the demand. The simple storage and easy usage of a single chamber design will help the market to grow
The dual-chamber segment will grow around 12% CAGR in the following year. Dual-chamber design allows solvents and ingredients to be separately filled. As the dual chamber design gives excellent storage and delivery of the medication, its demand will rise in the coming years.
Prefilled Syringes Market - By Application:
Prefilled Syringes Market - By Distribution Channel:
Prefilled Syringes Market - By Region:
Regionally, the North American market is dominating the global prefilled syringes market is estimated to be growing at CAGR of 10% during the forecast period. It is due to factors such as the increase in the prevalence of diabetes and autoimmune diseases, ageing of the population vulnerable to chronic diseases, further support the increase in incidence. Medicines and biologics approved for the treatment of these diseases should be given in prefilled syringes which are contributing to market development in this region.
The Asia-Pacific prefilled syringe market was worth more than the U.S. $ 900 million in 2018 and will witness significant growth during the forecast period. India and China have vast pools of diabetic patients, and many are still undiagnosed. Sedentary lifestyles and unhealthy eating habits can be associated with the increasing incidence of autoimmune and chronic diseases. As a result, the unsatisfactory demand for superior drug delivery systems is widespread in the region. Besides, the increase in disposable income in the area and the development of health infrastructure will accelerate the adoption of prefilled syringes during the forecast period.
TOP COMPANIES IN THE MARKET
Key market participants leading the global prefilled syringes market profiled in the report are Becton, Dickinson, and Company (U.S.), Gerresheimer AG (Germany), SCHOTT AG (Germany), West Pharmaceutical Services, Inc. (U.S.), Ompi (Italy), Catalent, Inc. (U.S.), Weigao Group (China), Vetter Pharma International GmbH (Germany), Nipro Corporation (Japan) and MedPro Inc. (U.S.).
RECENT DEVELOPMENTS IN GLOBAL PREFILLED SYRINGES INDUSTRY
In June 2019, Fresenius Kabi introduced the neostigmine methyl sulfate infusion, USP Simplist prefilled syringe in the United States. Expanding the product portfolio to a new geographic area will allow the company to capture a larger market share and survive competition in the industry.
In September 2018, Novartis announced that is has received the FDA approval for the prescription of a prefilled syringe with Xolair. It is the medicine used for signs of chronic idiopathic urticaria and asthma. Products approved by the FDA will help the company to have a competitive advantage.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Materials
5.1.1 Introduction
5.1.2 Glass Prefilled Syringes
5.1.3 Plastic Prefilled Syringes
5.1.4 Y-o-Y Growth Analysis, By Materials
5.1.5 Market Attractiveness Analysis, By Materials
5.1.6 Market Share Analysis, By Materials
5.2 Type
5.2.1 Introduction
5.2.2 Conventional Prefilled Syringes
5.2.3 Safety Prefilled Syringes
5.2.4 Y-o-Y Growth Analysis, By Type
5.2.5 Market Attractiveness Analysis, By Type
5.2.6 Market Share Analysis, By Type
5.3 Design
5.3.1 Introduction
5.3.2 Single-Chamber Prefilled Syringes
5.3.3 Dual Chamber Prefilled Syringes
5.3.4 Customized Prefilled Syringes
5.3.5 Y-o-Y Growth Analysis, By Design
5.3.6 Market Attractiveness Analysis, By Design
5.3.7 Market Share Analysis, By Design
5.4 Application
5.4.1 Introduction
5.4.2 Vaccines
5.4.3 Monoclonal Antibodies
5.4.4 Y-o-Y Growth Analysis, By Application
5.4.5 Market Attractiveness Analysis, By Application
5.4.6 Market Share Analysis, By Application
5.5 Distribution Channels
5.5.1 Introduction
5.5.2 Hospitals
5.5.3 Ambulatory Surgical Centres
5.5.4 Mail Order Pharmacies
5.3.5 Y-o-Y Growth Analysis, By Distribution Channels
5.3.6 Market Attractiveness Analysis, By Distribution Channels
5.3.7 Market Share Analysis, By Distribution Channels
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Materials
6.1.3.3 By Type
6.1.3.4 By Design
6.1.3.5 By Application
6.1.3.6 By Distribution Channels
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Materials
6.1.4.3 By Type
6.1.4.4 By Design
6.1.4.5 By Application
6.1.4.6 By Distribution Channels
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Materials
6.1.5.3 By Type
6.1.5.4 By Design
6.1.5.5 By Application
6.1.5.6 By Distribution Channels
6.2 North America
6.1.1 Introduction
6.1.2 United States
6.1.3 Canada
6.3 Europe
6.2.1 Introduction
6.2.2 U.K
6.2.3 Spain
6.2.4 Germany
6.2.5 Italy
6.2.6 France
6.4 Asia-Pacific
6.3.1 Introduction
6.3.2 China
6.3.3 India
6.3.4 Japan
6.3.5 Australia
6.3.6 South Korea
6.5 Latin America
6.4.1 Introduction
6.4.2 Brazil
6.4.3 Argentina
6.4.4 Mexico
6.4.5 Rest of Latin America
6.6 Middle East & Africa
6.5.1 Introduction
6.5.2 Middle-East
6.5.3 Africa
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 Becton
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Dickinson and Company
8.3 Gerresheeimer AG
8.4 SCHOTT AG
8.5 West Pharmaceutical Services
8.6 Ompi
8.7 Catalent Inc.
8.8 Weigao Group
8.9 Vetter Pharma International GmbH
8.10 Nirpo Corporation
8.11 MedPro Inc.
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
Related Reports
Feb 2020
Download Sample
Feb 2020
Download Sample
Feb 2020
Download Sample
Feb 2020
Download Sample
Feb 2020
Download Sample
